In AD and other tauopathies, accumulation of abnormally phosphorylated Tau is a hallmark of these diseases and is involved in fibril formation and neuron loss (Alonso et al., 1996, 2004; Hernández and Avila, 2007; Necula and Kuret, 2004). The gene discussed is MAPT; the disease is Alzheimer disease.